Institute of Anaesthesiology, Pain and Perioperative Medicine, Sir Ganga Ram Hospital, New Delhi, India.
Asian J Endosc Surg. 2022 Oct;15(4):765-773. doi: 10.1111/ases.13089. Epub 2022 May 31.
The focus on enhanced recovery after surgery (ERAS) and opioid-free anesthesia has renewed interest in use of lignocaine. We evaluated postoperative pain relief following intravenous (IV) lignocaine administration in patients undergoing laparoscopic intraperitoneal onlay mesh repair (IPOM).
Seventy patients were randomized into two groups. Group L patients were administered IV lignocaine infusion (1.5 mg/kg) at induction of anesthesia followed by infusion (1.5 mg/kg/h), until 1 hour in the post-anesthesia care unit (PACU). Group P patients received equal volumes of normal saline IV infusion. We recorded hemodynamics, perioperative analgesic consumption, postoperative visual analog scores (VAS), incidence of postoperative nausea and vomiting (PONV), bowel function, patient satisfaction and length of hospital stay (LOS).
The hemodynamics in both groups were maintained. Group L had lower VAS scores as compared to Group P (P < .05). Intraoperative fentanyl consumption in Group L was significantly less than Group P (P = .029). Group L patients scored lower on the Likert scale in comparison to the patients of Group P at 0 hour (P = .013). Recovery of bowel function as assessed by time to pass first flatus was significantly shortened by IV lignocaine (P = .001). The perioperative administration of IV lignocaine resulted in decreased postoperative analgesic requirement and greater patient satisfaction scores.
Perioperative IV lignocaine infusion provided good pain relief, hemodynamic stability and decreased perioperative analgesic consumption. PONV incidence decreased along with an early return of bowel function, reduced LOS and improved patient satisfaction in patients undergoing laparoscopic IPOM surgery.
强调手术后的快速康复(ERAS)和无阿片类药物麻醉,重新引起了人们对利多卡因使用的兴趣。我们评估了腹腔镜腹腔内覆盖网修补术(IPOM)患者静脉注射(IV)利多卡因给药后的术后疼痛缓解情况。
70 名患者随机分为两组。在麻醉诱导时,L 组患者给予 IV 利多卡因输注(1.5mg/kg),然后输注(1.5mg/kg/h),直到麻醉后护理单元(PACU)的 1 小时。P 组患者接受等量的生理盐水 IV 输注。我们记录了血流动力学、围手术期镇痛药物消耗、术后视觉模拟评分(VAS)、术后恶心和呕吐(PONV)的发生率、肠功能、患者满意度和住院时间(LOS)。
两组的血流动力学均保持稳定。与 P 组相比,L 组的 VAS 评分较低(P<0.05)。与 P 组相比,L 组术中芬太尼的消耗明显较少(P=0.029)。与 P 组相比,L 组患者在 0 小时时在李克特量表上的评分较低(P=0.013)。通过首次排气时间评估,IV 利多卡因可显著缩短肠功能恢复时间(P=0.001)。围手术期 IV 利多卡因的应用减少了术后镇痛的需求,并提高了患者的满意度评分。
围手术期 IV 利多卡因输注可提供良好的镇痛效果、血流动力学稳定,并减少围手术期镇痛药物的消耗。PONV 的发生率降低,同时肠功能早期恢复,住院时间缩短,患者满意度提高,腹腔镜 IPOM 手术患者获益。